# Spirus Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spirus-medical

- Industry: Medical Devices & Equipment
- Headquarters: West Bridgewater, US
- Website: www.spirusmedllc.com
- Total disclosed funding: $15M
- Latest round: Series B (May 14, 2009)
- Investors on record: 3

## About

Spirus Medical, Inc. is a developer of innovative medical devices for gastrointestinal and cardiovascular endoscopic procedures, enhancing the efficiency and effectiveness of these medical interventions.Spirus Medical, Inc. specializes in creating advanced medical devices for endoscopic procedures, including gastroenterology and cardiology. The company was acquired by Olympus Corporation in July 2011. Based in West Bridgewater, US, Spirus Medical has conducted a total of 4 deals. Their latest funding round was Series B, raising USD 0.630 mn, bringing the total amount raised to USD 0.630 mn with a current company valuation of USD 32.585 mn. The company has received investments from BioVentures Investors and PJC.Spirus Medical, LLC focuses on developing innovative medical devices for gastrointestinal and cardiovascular endoscopic procedures. Their flagship products include the Endo-Ease Discovery® SB for enteroscopy and the Vista® Retrograde for colonoscopy, featuring unique rotate-to-advance technology. Additionally, the Dexterity™ Steerable Introducer offers easy access to heart anatomy for improved procedural outcomes. These products target healthcare providers such as gastroenterologists and cardiologists in North America and Europe, where there is an increasing demand for enhanced endoscopic solutions.Spirus Medical generates revenue through direct business-to-business sales to healthcare facilities, including hospitals and specialty clinics. Their main revenue streams come from the sale of proprietary devices like the Endo-Ease Discovery® SB, Vista® Retrograde, and Dexterity™ Steerable Introducer, typically through contract agreements. Each sale is negotiated based on volume and product specifications, aligning pricing with the advanced technology of their devices. The company maintains ongoing relationships with clients, providing support and training for effective device usage.Spirus Medical plans to leverage recent funding to support the development of new products aimed at enhancing endoscopic procedures. The company is focused on expanding its market presence in North America and Europe, specifically targeting regions with increasing healthcare demands by the end of 2013. The acquisition by Olympus Corporation is expected to facilitate these growth initiatives, aligning Spirus Medical with a larger network and resources for product development and distribution.

## Funding rounds

- Series B, May 14, 2009, $0.6M — BioVentures Investors, PJC
- Series B, Apr 19, 2007, $8.5M — BioVentures Investors, Village Ventures, PJC
- Series A, Dec 20, 2005, $5.9M — BioVentures Investors, Village Ventures, PJC

## Investors

- BioVentures Investors (https://capitalatlas.ai/funds/bioventures-investors) — Series A, Series B
- Village Ventures (https://capitalatlas.ai/funds/village-ventures) — Series A, Series B
- PJC (https://capitalatlas.ai/funds/pjc) — Series A, Series B